Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | mitogen-activated protein kinase, putative,map kinase-like protein | 0.0022 | 0 | 0.5 |
Echinococcus granulosus | cyclin dependent kinase 9 | 0.0065 | 0.0263 | 0.0263 |
Giardia lamblia | Kinase, CDC7 | 0.1682 | 1 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.0022 | 0 | 0.5 |
Leishmania major | serine/threonine kinase-like protein, putative | 0.0022 | 0 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.1682 | 1 | 1 |
Schistosoma mansoni | kinase | 0.0057 | 0.0217 | 0.0217 |
Echinococcus multilocularis | CDC7 cell division cycle 7 | 0.1682 | 1 | 1 |
Plasmodium vivax | serine/threonine protein kinase KIN, putative | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.1682 | 1 | 1 |
Trypanosoma cruzi | Mitogen-activated protein kinase 10, putative | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.1682 | 1 | 1 |
Echinococcus multilocularis | cyclin dependent kinase 9 | 0.0057 | 0.0217 | 0.0217 |
Loa Loa (eye worm) | CMGC/CDK/CDK9 protein kinase | 0.0057 | 0.0217 | 0.0217 |
Plasmodium falciparum | MO15-related protein kinase | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.1682 | 1 | 1 |
Onchocerca volvulus | 0.1682 | 1 | 0.5 | |
Plasmodium vivax | cyclin dependent kinase 7 (cdk7), putative | 0.0022 | 0 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0057 | 0.0217 | 0.0217 |
Brugia malayi | cyclin-dependent kinase 9 | 0.0057 | 0.0217 | 0.0217 |
Trypanosoma cruzi | serine/threonine protein kinase, putative | 0.0022 | 0 | 0.5 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0057 | 0.0217 | 1 |
Trypanosoma cruzi | Mitogen-activated protein kinase 10, putative | 0.0022 | 0 | 0.5 |
Loa Loa (eye worm) | CDC7 protein kinase | 0.1682 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0248 | 0.1363 | 0.1363 |
Echinococcus granulosus | cyclin dependent kinase 9 | 0.0057 | 0.0217 | 0.0217 |
Echinococcus granulosus | CDC7 cell division cycle 7 | 0.1682 | 1 | 1 |
Onchocerca volvulus | 0.1682 | 1 | 0.5 | |
Echinococcus multilocularis | cyclin dependent kinase 9 | 0.0065 | 0.0263 | 0.0263 |
Trypanosoma brucei | Mitogen-activated protein kinase 10, putative | 0.0022 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 3.13 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Bacillus subtilis | ChEMBL. | 15686916 |
MIC (functional) | = 3.13 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Schizosaccharomyces pombe | ChEMBL. | 15686916 |
MIC (functional) | = 6.25 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Pseudomonas aeruginosa | ChEMBL. | 15686916 |
MIC (functional) | = 6.25 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Rhodotorula rubra | ChEMBL. | 15686916 |
MIC (functional) | = 12.5 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Staphylococcus aureus | ChEMBL. | 15686916 |
MIC (functional) | = 12.5 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Aspergillus niger | ChEMBL. | 15686916 |
MIC (functional) | = 12.5 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Penicillium chrysogenum | ChEMBL. | 15686916 |
MIC (functional) | = 25 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Rhizopus chinensis | ChEMBL. | 15686916 |
MIC (functional) | = 25 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Mucor mucedo | ChEMBL. | 15686916 |
MIC (functional) | = 25 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Saccharomyces cerevisiae | ChEMBL. | 15686916 |
MIC (functional) | = 25 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Candida utilis | ChEMBL. | 15686916 |
MIC (functional) | = 25 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Saccharomyces cerevisiae | ChEMBL. | 15686916 |
MIC (functional) | = 50 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Proteus vulgaris | ChEMBL. | 15686916 |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Escherichia coli | ChEMBL. | 15686916 |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration of the compound was determined against Escherichia coli | ChEMBL. | 15686916 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.